Not yet recruiting
Diabetic neuropathy+2
Not yet recruitingEfficacy and Safety of OXT-328 5% Topical Gel for Symptom Relief in Patients with Chemotherapy‑Induced, Diabetic, and Cervical Radiculopathy Peripheral Neuropathy
InvestigationalNo placebo
Efficacy and Safety of OXT-328 5% Topical Gel for Symptom Relief in Patients with Chemotherapy‑Induced, Diabetic, and Cervical Radiculopathy Peripheral Neuropathy
InvestigationalNo placebo
- Disease:Diabetic neuropathyNeuropathy peripheral+1
- Substances:–
Countries:
Greece
Greece- Participants:18–64 years · 65+ years
- Sponsor:Jcare Pharmaceuticals LLC

